Lincoln Electric Reports First Quarter 2020 Results
CLEVELAND, April 27, 2020 (GLOBE NEWSWIRE) — Lincoln Electric Holdings, Inc. (the “Company”) (Nasdaq: LECO) today reported first quarter 2020 net […]
Orgenesis Completes Acquisition of Tamir Biotechnology, Inc. Assets Including Broad Spectrum Antiviral Platform
GERMANTOWN, Md., April 27, 2020 (GLOBE NEWSWIRE) — Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a pioneering, global biotech company […]
PAE Supports the Government of Canada’s Health Preparedness Efforts through Joint Venture with SNC-Lavalin
Falls Church, Va., April 27, 2020 (GLOBE NEWSWIRE) — PAE (NASDAQ: PAE, PAEWW), through its SNC-Lavalin PAE Inc. joint venture, […]
Harrow Health to Announce First Quarter 2020 Financial Results on May 11, 2020
NASHVILLE, Tenn., April 27, 2020 (GLOBE NEWSWIRE) — Harrow Health, Inc. (NASDAQ: HROW) today announced that after the close of […]
So-Young International Inc. Files Its Annual Report on Form 20-F
BEIJING, China, April 27, 2020 (GLOBE NEWSWIRE) — So-Young International Inc. (Nasdaq: SY) (“So-Young” or the “Company”), the largest and […]
DASAN Zhone Solutions Sets First Quarter 2020 Earnings Call for Thursday, May 7, 2020 at 5:00 p.m. ET
ALAMEDA, Calif., April 27, 2020 (GLOBE NEWSWIRE) — DASAN Zhone Solutions, Inc. (NASDAQ: DZSI or the “Company” or “DZS”), a […]
Six COVID-19 Patients Treated with RedHill’s Opaganib Under Compassionate Use Show Objective Clinical Improvement
Preliminary data in moderate-to-severe COVID-19 patients treated with opaganib show measurable clinical improvement in all six patients analyzed, including decreased […]
Atomera Announces Rescheduling of Annual Meeting of Stockholders
LOS GATOS, Calif., April 27, 2020 (GLOBE NEWSWIRE) — Atomera Incorporated (NASDAQ: ATOM) announced today that its 2020 Annual Meeting […]
Dorman Products, Inc. Reports First Quarter 2020 Results
Highlights:Net sales of $257.7 million, up 6% compared to $243.8 million in Q1 2019. Diluted earnings per share (EPS) on a […]
Avadel Pharmaceuticals Announces Positive Topline Results from its Pivotal Phase 3 REST-ON Trial of Once-Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients with Narcolepsy
The primary analysis of investigational, once-nightly FT218 at 9 g demonstrated highly statistically significant (p<0.001), and clinically meaningful improvement across […]
